Page 4 - Mitchell Kronenberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

With an FDA decision on boosters expected as early as Wednesday, people waiting on a final recommendation respond with relief, eager anticipation.

Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board Proceeds will be used to progress stem cell derived CAR-engineered invariant natural killer T cells (CAR-iNKT) to the clinic in hematological and solid tumor indications News provided by Share this article Share this article LOS ANGELES, May 11, 2021 /PRNewswire/ -- Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients, today announced its launch from stealth backed by $52 million Series A fina...

Print Erica Ollmann Saphire, a biologist known internationally for her efforts to fight such deadly viruses as COVID-19 and Ebola, has been named president and chief executive officer of the La Jolla Institute, one of the country’s foremost private biomedical research centers. Saphire, 49, will succeed Mitchell Kronenberg, who has led LJI for nearly 20 years. He will remain as chief scientific officer. She will continue to run her lab, which serves as a global clearinghouse in the search for antibodies that might be effective against COVID-19, which has killed 2.65 million people. Her appo...

Erica Ollmann Saphire appointed president and CEO of La Jolla Institute for Immunology Dr. Erica Ollmann Saphire Dr. Saphire will become La Jolla Institute’s fifth president when she formally begins her term on September 1, 2021. She will succeed current LJI President Mitchell Kronenberg, who has successfully led the organization for the past 18 years. “I am deeply honored to be asked to carry La Jolla Institute forward and lead such an exceptional group of immunologists and staff,” said Dr. Saphire. “LJI shines as one of the top immunology research organizations globally. I am excite...

A gift from John and Susan Major will fund construction of a new clinical center at the La Jolla Institute for Immunology. Rendering courtesy of La Jolla Institute for Immunology. The La Jolla Institute for Immunology has announced plans for new construction after receiving a gift from John Major, chairman emeritus of the institute’s board of directors, and his wife, Susan. The La Jolla Institute (LJI) announced the gift on Dec. 28. Financial terms were undisclosed. Funds will go toward the construction of a new clinical research center. The John and Susan Major Center for C...